Male androgenetic alopecia

Bibliography

• Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc 2005;10:184-9
   PubMedGoogle Scholar
• Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992;26:926-31
   PubMed Web of Science ®Google Scholar
• Lee HJ, Ha SJ, Kim D, Perception of men with androgenetic alopecia by women and non balding men. Inter J Dermatol 2002;41(12):867-9
   Google Scholar
• Oslen EA. Female pattern hair loss: clinical features and potential hormonal factors. J Am Acad Dermatol 2001;45:570-80
   Google Scholar
• Lee WS, Ro BI, Hong SP, A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. J Am Acad Dermatol 2007;57(1):37-46
   Google Scholar
• Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-54
   PubMed Web of Science ®Google Scholar
• Van Scott EJ, Ekel TM. Geometric relationaships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol 1958;31:281-7
   PubMedGoogle Scholar
• Elliot K, Stephenson TJ, Messenger AG. Differences in the hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size androgen responses. J Invest Dermatol 1999;113:873-7
   Google Scholar
• Jahoda CAB. Cellular and developmental aspects of androgenetic alopecia. EXP Dermatol 1998;7:235-48
   PubMed Web of Science ®Google Scholar
• Hamilton JB. Patterned loss of hair in man: types and incidence. Annal NY Acad Sci 1951;53:708-28
   PubMed Web of Science ®Google Scholar
• Van Neste D, Fuh V, Sacchiez-Pedreno P, Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000;143:804-10
   PubMed Web of Science ®Google Scholar
• Yazdabadi A, Magee J, Harrison S, Sinclair R. The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit. Br J Dermatol 2008;159:1300-2
   PubMed Web of Science ®Google Scholar
• de Berker DAR, Messenger AG, Sinclair RD. Disorders of hair. In: Burns T, Breathnach S, Cox N, Griffiths C, editors, Rook's textbook of dermatology. 7th edition. (Volume 4). Blackwell Publishing; 2004. pp. 63. 8-63.10
   Google Scholar
• Botchkarev VA, Kishimoto J. Molecular control of epithelial-mesenchymal interactions during hair follicle cycling. J Investig Dermatol Symp Proc 2003;8:46-55
   PubMedGoogle Scholar
• Curtois M, Loussouarn G, Horseau C. Hair cycle and alopecia. Skin Pharm 1994;7:84-9
   Google Scholar
• Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol 2003;121:1561-4
   PubMed Web of Science ®Google Scholar
• Koster W, Happle R. The inheritance of baldness: two B or not two B? J Am Acad Dermatol 1984;11:921-6
   Google Scholar
• Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5 alpha reductase genes. J Invest Dermatol 1998;110:849-53
   PubMedGoogle Scholar
• Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Investig Dermatol 2001;116:452-5
   PubMed Web of Science ®Google Scholar
• Sinclair R, Greenland KJ, Egmond S, Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 2007;157(2):290-4
   Google Scholar
• Hillmer AM, Flaquer A, Hanneken S, Genome-wide scan and Fine-Mapping Linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 2008;82:737-43
   PubMed Web of Science ®Google Scholar
• Hillmer AM, Brockschmidt FF, Hanneken S, Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008;40(11):1279-81
   Google Scholar
• Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5 alpha reductase genes. J Invest Dermatol 1998;110:849-53
   PubMedGoogle Scholar
• Sawaya ME, Price VH. Different levels of 5 alpha reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;109:296-300
   PubMed Web of Science ®Google Scholar
• Yip L, Zaloumis S, Irwin D, Gene-wide association study of the aromatase gene (CYP19A1) with female pattern hair loss. Br J Dermatol 2009;161(2):289-94
   Google Scholar
• Ellis JA, Harrap SB. The genetics of androgenetic alopecia. Clin Dermatol 2001;19:149-54
   PubMed Web of Science ®Google Scholar
• Hamilton JB. Male hormone stimulation is prerequisite and an insitant in common baldness. AM J Anat 1942;71:451-80
   Google Scholar
• Williams GR, Franklyn JA, Physiology of the steroid-thyroid hormone nuclear receptor superfamily. Baillieres Clin Endocrinol Metab 1974;38:811-19
   Google Scholar
• Patterson MN, McPhaul MJ, Hughes IA. Androgen insensitivity syndrome. Baillieres Clin Endocrinol Metab 1994;8:379-404
   Google Scholar
• Jenkins EP, Andersson S, Imperato McGinley J, Genetic and pharmacological evidence for more than one human steroid 5-alpha-reductase. J Clin Invest 1992;89:293-300
   PubMed Web of Science ®Google Scholar
• Imperato McGinley J. % alpha reductase 2 deficiency and complete androgen insensitivity: lesions from nature. Adv Exp Med Biol 2002;511:121-34
   Google Scholar
• Kaufman KD, Olsen EA, Whiting D, Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-89
   PubMed Web of Science ®Google Scholar
• Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann NY Acad Sci 1959;83:463-79
   PubMed Web of Science ®Google Scholar
• Nordstrom REA. Synchronous balding of scalp and hair bearing grafts of scalp transplanted to the skin of the arm in male pattern baldness. Acta Derm Venereol (Stockh) 1979;59:266-8
   PubMedGoogle Scholar
• Itami S, Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc 2005;10(3):209-11
   Google Scholar
• Hamilton JB. Patterned hair loss in men: types and incidence. Ann NY Acad Sci 1951;53:708-14
   PubMed Web of Science ®Google Scholar
• Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359-70
   PubMed Web of Science ®Google Scholar
• De Lacharriere O, Deloche C, Misciali C, Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch Dermatol 2001;137:641-6
   PubMedGoogle Scholar
• Kosman ME. Evaluation of a new antihypertensive agent: minoxidil. JAMA 1980;244:73-5
   Google Scholar
• Devine Bl, Fife R, Trust PM. Minoxidil for severe hypertention after failure of other hypotensive agents. Br Med J 1977;2:667-9
   Google Scholar
• Jacobs D. Minoxidil experience in Australia 1974-1980. Med J Aust 1981;1:477-8
   Google Scholar
• Pennisi AJ, Takahashi M, Bernstein BH, Minoxidil therapy in children with severe hypertension. J Paediatr 1977;90:813-19
   Web of Science ®Google Scholar
• Kreindler TG. Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol 1987;16:718-24
   PubMed Web of Science ®Google Scholar
• Roberts JL. Androgenetic alopecia: treatment results with topical minoxidil. J Am Acad Dermatol 1987;16:705-10
   PubMed Web of Science ®Google Scholar
• Rundegren J, Westin A, Kohut B. Hair growth efficacy assessment of a new topical minoxidil foam formulation in the stump-tail macaque. J invest Dermatol 2005;587:A98
   Google Scholar
• Olsen EA, Weiner MS, Amara IA, DeLong ER. Five year follow up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol 1990;22:643-6
   PubMed Web of Science ®Google Scholar
• Wester RC, Maibach HI, Guy RH, Nowak E. Minoxidil stimulates cutaneous blood flow in human balding scalp: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 1984;82:515-17
   Google Scholar
• Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998;138:407-11
   PubMed Web of Science ®Google Scholar
• Li M, Marubayashi A, Nakaya Y, Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol 2001;117(6):1594-600
   Google Scholar
• Buhl AE, Conrad SJ, Waldon DJ, Pottasium channel conductance as a control mechanism in hair follicles. J Invest Dermatol 1993;101:148s-52s
   PubMed Web of Science ®Google Scholar
• Buhl AE, Waldon DJ, Conrad SJ, Pottasium channel conductance: a mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol 1992;98:315-19
   PubMed Web of Science ®Google Scholar
• Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: atiology and treatment. J Am Acad Dermatol 2002;46:309-12
   PubMed Web of Science ®Google Scholar
• Rhodes L, Harper J, Uno H, The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone in adult male and female stump-tail macaques (Macaca arctoides). J Clin Endocrinol Metab 1994;29:991-6
   Google Scholar
• Drake L, Hordinsky M, Fiedler V, The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999;41:550-4
   PubMed Web of Science ®Google Scholar
• Kaufman KD, Olsen EA, Whiting D, Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-89
   PubMed Web of Science ®Google Scholar
• Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49
   Google Scholar
• Stough DB, Rao NA, Kaufman KD, Mitchell C. Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol 2002;12:32-7
   PubMed Web of Science ®Google Scholar
• Van Neste D, Fuh V, Sanchez Pedreno P, Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000;143:804-10
   PubMed Web of Science ®Google Scholar
• Arca E, Acikgoz G, Tastan HB, An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology 2004;209(2):117-25
   Google Scholar
• Wilton L, Pearce G, Edet E, The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients. Br J Urol 1996;78:379-84
   PubMedGoogle Scholar
• Rihimi-Ardabili B, Pourandarjani R, Habibollahi P, Mualeki A. Finasteride-induced depression: a prospective study. BMC Clin Pharmacol 2006;6:7
   Google Scholar
• D'Amico AV, Roehrborn CG. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol 2007;8(1):21-5
   Google Scholar
• Thompson IM, Goodman PJ, Tangen CM, The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24
   PubMed Web of Science ®Google Scholar
• Olsen EA, Hordinsky M, Whiting D, The importance of dual 5-alpha reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride vs. finasteride. J Am Acad Dermatol 2006;55:1014-23
   PubMed Web of Science ®Google Scholar
• Stough D. Dutasteride improves male pattern hair loss in a randomized study in identical twins. J Cosmet Dermatol 2007;6:9-13
   PubMedGoogle Scholar
• Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol 2005;4:637-40
   PubMedGoogle Scholar
• Okuda S. The study of clinical experiments of hair transplantation. Jpn J Dermatolurol 1939;46:135
   Google Scholar
• Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann NY Acad Sci 1959;83:463-79
   PubMed Web of Science ®Google Scholar
• Bernstein RM, Rassman WR, Szaniawski W, Halperin A. Follicular transplantation. Intl J Aest Restor Surg 1995;3:119-32
   Google Scholar
• Wolf R, Matz H, Zalish M, Prostaglandin analogs for hair growth: great expectations. Dermatol Online J 2003;9:7
   PubMedGoogle Scholar
• Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005;152:466-73
   PubMed Web of Science ®Google Scholar
• Vexiau P, Chaspoux C, Boudou P, Effect of 2% minoxidil vs cyproterone acetate on female androgenetic alopecia: a controlled, 12 months randomised trial. Br J Dermatol 2002;146:992-9
   PubMed Web of Science ®Google Scholar
• Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002;29(8):489-9
   Google Scholar
• Kassimir JJ. Use of topical minoxidil as a possible adjunct to hair transplant surgery. A pilot study. J Am Acad Dermatol 1987;16:685-7
   PubMed Web of Science ®Google Scholar
• Roenigk HH, Berman MD. Topical 2% minoxidil with hair transplantation. Face 1993;4:213-16
   Google Scholar
• Leavitt M, Perez-Meza D, Rao NA, Effects of finasteride (1 mg) on hair transplant. J Dermatol Surg 2005;31:1268-76
   Google Scholar